Money's flowing back into small caps, China's testing leverage, and a biotech solves a 40-year puzzle around a shelved cancer drug
Weekly Wrap: Gold's Seventh Heaven, BHP v…
Money's flowing back into small caps, China's testing leverage, and a biotech solves a 40-year puzzle around a shelved cancer drug